Schedule 13G ownership disclosure

PLUS THERAPEUTICS INC

Security class unavailable · CUSIP: 72941H400

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
230,769
Percent of class
4.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-21-000168
Form type
SC 13G
Filer
NanoTx, Corp.
CIK
CIK 1812069
Filed
Feb 26, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub